Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability

Sponsor
National Institute on Aging (NIA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00417313
Collaborator
(none)
88
1
22
4

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the feasibility, effectiveness, and duration of treatment response of periosteal electro-acupuncture (osteopuncture) for osteoarthritis (OA)-associated chronic knee pain.

Condition or Disease Intervention/Treatment Phase
  • Device: periosteal electro-acupuncture (osteopuncture).
Phase 2

Detailed Description

Knee osteoarthritis (OA) is painful in 6.8% of men and 11.4% of women age 63-93, with over 20 million Americans affected nationwide, and may lead to a variety of untoward consequences including limitations in physical function, postural instability, sleep disturbance, psychosocial disability, and substantial utilization of health care resources. While oral analgesics represent the mainstay of treatment for chronic pain associated with knee OA, non-responders with limiting comorbidities may have few therapeutic alternatives.

The aims of this research study are to (1) reduce pain severity and disability in community-dwelling older adults with OA-associated chronic knee pain using periosteal electroacupuncture (osteopuncture), and (2) improve the physical performance, psychosocial function, sleep, and appetite of these individuals. 88 older adults with persistent knee pain and x-ray evidence of OA, no other rheumatologic disorders, no history of knee surgery, and no prominent pain in sites other than the knee(s) will be randomized to receive either osteopuncture or control osteopuncture once a week for 6 weeks. All outcome measures for pain and disability, as well as physical performance, psychosocial function, sleep, and appetite, will be collected pre-treatment, at the completion of the 6-week protocol, and 3 months later.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability
Study Start Date :
Oct 1, 2004
Study Completion Date :
Aug 1, 2006

Outcome Measures

Primary Outcome Measures

  1. changes in pain and disability, measured with the Western Ontario and McMaster Universities Osteoarthritis Index []

Secondary Outcome Measures

  1. changes in physical performance []

  2. psychosocial function (mood, self-efficacy, coping, fear, self-rated health) []

  3. sleep and appetite []

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Radiographic evidence of knee OA on a standing AP X-ray

  • Bilateral knee pain for at least 3 months with pain of at least moderate intensity every day or almost every day

Exclusion Criteria:
  • Non-ambulatory, or severely impaired mobility (i.e., require the use of a walker)

  • Folstein Mini-Mental State Examination score of less than 24

  • Severe visual or hearing impairment

  • Knee pain due to factors other than OA, e.g. rheumatoid or psoriatic arthritis, gout, pseudogout, metastatic cancer

  • Significant pain in parts of the body other than the knee or acute knee pain

  • A large knee effusion or severe mechanical instability of the knee

  • History of corticosteroid injection in the affected knee(s) during the preceding 3 months

  • History of hyaluronic acid injection in the affected knee(s) during the preceding 3 months

  • Acute or terminal illness

  • Immune suppression

  • Anticoagulation therapy

  • Presence of a pacemaker

  • Prior acupuncture treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pain Evaluattion and Treatment Institute, Research Department Pittsburgh Pennsylvania United States 15206

Sponsors and Collaborators

  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Debra K Weiner, MD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00417313
Other Study ID Numbers:
  • AG0073
  • 5R21AG024288-02
First Posted:
Jan 1, 2007
Last Update Posted:
Jan 1, 2007
Last Verified:
Dec 1, 2006

Study Results

No Results Posted as of Jan 1, 2007